|
|
||||||||
AJP - Renal Physiology, Vol 261, Issue 5 779-F786, Copyright © 1991 by American Physiological Society
ARTICLES |
J. Radermacher, B. Klanke, S. Kastner, G. Haake, H. J. Schurek, H. F. Stolte and J. C. Frolich
Department of Clinical Pharmacology, Hannover Medical School, Federal Republic of Germany.
The effect of L-Arg depletion on glomerular hemodynamics and tubular function of isolated rat kidneys perfused with a medium containing 21 amino acids has been studied. A cyclooxygenase inhibitor was added throughout for blockade of prostaglandin synthesis. Arg depletion caused significant (approximately 30%) reductions in renal perfusion flow rate (PFR, 13.9 +/- 1.2 vs. 19.8 +/- 0.6 ml.min-1.g (kidney wt-1), glomerular filtration rate (GFR, 598 +/- 79 vs. 924 +/- 42 microliters.min-1.g kidney wt-1), and urine flow rate (139 +/- 38 vs. 192 +/- 13 microliters.min-1.g kidney wt-1) compared with control kidneys, which were perfused with a physiological concentration of Arg (200 microM). Filtration fraction (FF) increased with Arg depletion (5.1 +/- 0.4 vs. 4.4 +/- 0.4%). Arg-depleted kidneys had a lower absolute sodium (TNa, 75.7 +/- 8.8 vs. 107.9 +/- 6.0 mumol.min-1.g kidney wt-1) and glucose reabsorption (T glucose, 3.7 +/- 0.6 vs. 5.6 +/- 0.5 mumol.min-1.g kidney wt-1), corresponding to a lower sodium and glucose filtration. Potassium handling and reabsorption of free water were not changed. Oxygen consumption (QO2) was lower in Arg-depleted kidneys (4.6 +/- 0.3 vs. 5.5 +/- 0.5 mumol.min-1.g kidney wt-1). The effects of Arg depletion were completely reversed by the addition of Arg (1 mM) at 120 min and partly reversed by the addition of citrulline (1 mM). Ornithine depletion or addition had no effect on PFR, GFR, FF, TNa, T glucose, and QO2. N omega-methyl-L-arginine, a specific inhibitor of nitric oxide endothelium-derived relaxing factor, produced the same effect as Arg depletion.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
M. Kakoki, H.-S. Kim, C.-J. S. Edgell, N. Maeda, O. Smithies, and D. L. Mattson Amino acids as modulators of endothelium-derived nitric oxide Am J Physiol Renal Physiol, August 1, 2006; 291(2): F297 - F304. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kakoki, H.-S. Kim, W. J. Arendshorst, and D. L. Mattson L-Arginine uptake affects nitric oxide production and blood flow in the renal medulla Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1478 - R1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wu, B. Cholewa, and D. L. Mattson Characterization of L-arginine transporters in rat renal inner medullary collecting duct Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1506 - R1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Luyckx, F. O. Goda, D. B. Mount, T. Nishio, A. Hall, S. C. Hebert, T. G. Hammond, and A. S. L. Yu Intrarenal and subcellular localization of rat CLC5 Am J Physiol Renal Physiol, November 1, 1998; 275(5): F761 - F769. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Higaki, T. Yukawa, M. Takeuchi, K. Nezasa, and M. Nakano Stereoselective Uptake of an Organic Anion Across the Renal Basolateral Membrane in Isolated Perfused Rat Kidney Drug Metab. Dispos., February 1, 1998; 26(2): 138 - 145. [Abstract] [Full Text] |
||||
![]() |
X. Deng, W. J. Welch, and C. S. Wilcox Renal Vasodilation With L-Arginine : Effects of Dietary Salt Hypertension, August 1, 1995; 26(2): 256 - 262. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |